Vaginal Creams, Foams, and Jellies (Vaginal Tablet)

Subscribe to Selected New Research on Vaginal Creams, Foams, and Jellies

226 relevant articles (37 outcomes, 53 trials/studies) found for this Bio-Agent

Description: Medicated dosage forms for topical application in the vagina. A cream is a semisolid emulsion containing suspended or dissolved medication; a foam is a dispersion of a gas in a medicated liquid resulting in a light, frothy mass; a jelly is a colloidal semisolid mass of a water soluble medicated material, usually translucent.

Also Known As:

Vaginal Tablet; Vaginal Tablets; Vaginal Cream; Vaginal Creams; Vaginal Foam; Vaginal Foams; Vaginal Gel; Vaginal Jellies; Vaginal Jelly; Cream, Vaginal; Creams, Vaginal; Foam, Vaginal; Foams, Vaginal; Gel, Vaginal; Gels, Vaginal; Jellies, Vaginal; Jelly, Vaginal; Tablet, Vaginal; Tablets, Vaginal; Vaginal Gels; Vaginal Creams, Foams and Jellies

Relationship Network

Bio-Agent Context: Research Results

Pharmaceutical Preparations

Dosage Forms: 327

Vaginal Creams, Foams, and Jellies: 226

Chemical Actions and Uses

Specialty Uses of Chemicals

Dosage Forms: 327

Vaginal Creams, Foams, and Jellies: 226

Equipment and Supplies

Feminine Hygiene Products: 1

Vaginal Creams, Foams, and Jellies: 226

Experts

1.	Milani, Massimo: 3 articles (06/2005 - 07/2003)
2.	Skokos, Campbell K: 2 articles (12/2005 - 09/2005)
3.	Molteni, Bruno: 2 articles (06/2005 - 06/2004)
4.	Agnello, Antonella: 2 articles (06/2004 - 07/2003)
5.	Barcellona, Eliana: 2 articles (06/2004 - 07/2003)
6.	Lobo, Rogerio A: 1 article (01/2008)
7.	Feldblum, Paul J: 1 article (01/2008)
8.	Bachmann, Gloria: 1 article (01/2008)
9.	Lendvay, Anja: 1 article (01/2008)
10.	Wang, Lily: 1 article (01/2008)

Related Diseases

1.	Bacterial Vaginosis 06/01/2005 - "OBJECTIVE: We evaluated the efficacy of a mucoadhesive vaginal gel (MVG, Miphil) with acidic-buffering properties in bacterial vaginosis (BV). " 01/01/2009 - "The purpose of this study was to determine the effectiveness of Lactobacillus-containing vaginal tablets in the treatment of bacterial vaginosis (BV) and in the restoration of a healthy vaginal flora. " 04/01/1994 - "Within this study, women with bacterial vaginosis (16 to 27 week' gestation) were treated with 2% clinadmycin vaginal cream or placebo. " 01/01/2009 - "Effectiveness of Lactobacillus-containing vaginal tablets in the treatment of symptomatic bacterial vaginosis." 11/01/2005 - "Recurrent bacterial vaginosis: the use of maintenance acidic vaginal gel following treatment." Order ALL the reference details at left...
2.	Vulvovaginal Candidiasis 01/01/1983 - "A comparison of the efficacy of two vaginal creams for vulvovaginal candidiasis, and correlations with the presence of Candida species in the perianal area and oral contraceptive use." 04/01/2009 - "2% butoconazole nitrate vaginal cream is modern and up to date option for treatment of acute vulvovaginal candidiasis. " 04/01/2009 - "[The statement of Polish Gynecological Society Experts on the treatment of acute vulvovaginal candidiasis with prolonged releasing 2% butoconazole nitrate vaginal cream--state of art in 2008]" 06/01/2006 - "Single-dose sertaconazole vaginal tablet treatment of vulvovaginal candidiasis." 11/01/1986 - "Butoconazole vaginal cream in the treatment of vulvovaginal candidiasis. " Order ALL the reference details at left...
3.	Atrophy 11/01/2008 - "OBJECTIVE: To evaluate the efficacy of ultra-low-dose 10-microgram 17beta-estradiol (E2) vaginal tablets for treatment of vaginal atrophy. " 01/01/2008 - "CONCLUSION: Vaginal tablets with 25 mcg and 10 mcg E2 provided relief of vaginal symptoms, improved urogenital atrophy, decreased vaginal pH, and increased maturation of the vaginal and urethral epithelium. " 01/01/2003 - "Action of 25 microg 17beta-oestradiol vaginal tablets in the treatment of vaginal atrophy in Greek postmenopausal women; clinical study." 01/01/2009 - "Signs and symptoms of vaginal atrophy were measured by anamnesis, visual examination and the maturation index before and after 12 weeks' treatment with 17beta-oestradiol in the form of vaginal tablets. " 10/01/1997 - "Vagifem, a new vaginal tablet containing 25 microg 17beta-estradiol, may fulfill many of the criteria required of an agent for the effective and efficient management of urogenital atrophy." Order ALL the reference details at left...
4.	Vaginitis 01/01/2003 - "CONCLUSIONS: The twice-weekly local single treatment with vaginal tablets containing 25 microg of 17beta-oestradiol was effective and safe for the relief of symptoms related to atrophic vaginitis in postmenopausal women from the Greek population." 01/01/2005 - "CONCLUSION: Low-dose 17beta-estradiol vaginal tablets in the treatment of the postmenopausal atrophic vaginitis constitutes an extremely valid approach in terms of effectiveness and safety." 01/01/2005 - "PATIENTS AND METHODS: 325 postmenopausal women with atrophic vaginitis in estrogenic replacement therapy with 0.025 mg 17beta-estradiol vaginal tablets, one application each day for two weeks, and a single application two times a week for the following 22 weeks (total treatment period: 24 weeks). " 01/01/2005 - "PURPOSE OF INVESTIGATION: To verify the effectiveness and safety of low-dose 17beta-estradiol vaginal tablets in the treatment of the postmenopausal atrophic vaginitis. " 01/01/2005 - "Local estrogen replacement therapy in postmenopausal atrophic vaginitis: efficacy and safety of low dose 17beta-estradiol vaginal tablets." Order ALL the reference details at left...
5.	Infection 12/01/2008 - "Development and in vitro evaluation of an acid buffering bioadhesive vaginal gel for mixed vaginal infections." 01/01/2007 - "An acid-buffering bioadhesive vaginal tablet was developed for the treatment of genitourinary tract infections. " 01/01/2007 - "Development and evaluation of acid-buffering bioadhesive vaginal tablet for mixed vaginal infections." 10/01/2005 - "Of 38,151 controls, 846 (2.2%) had treatment with vaginal tablet of M+M for vaginal infections. " 05/01/1982 - "In the HSV-2 genital infection of guinea pigs, treatment with 10% vaginal creams or placebo vehicle was initiated 6 or 24 h after viral inoculation. " Order ALL the reference details at left...

Related Drugs and Biologics

1.	Clindamycin (Cleocin)
2.	Clotrimazole (Lotrimin)
3.	Metronidazole (Metric)
4.	Vaginal Creams, Foams, and Jellies (Vaginal Tablet)
5.	Estradiol (Estrace)
6.	Econazole
7.	Tablets
8.	Progesterone
9.	Fluconazole (Zonal)
10.	Dinoprostone (PGE2)

Related Therapies and Procedures

1.	Pessaries
2.	Contraception (Birth Control)
3.	Intrauterine Devices (Intrauterine Device)
4.	Female Contraceptive Devices (Vaginal Ring)
5.	Cesarean Section (Caesarean Section)

Best Treatments:
Research Summary Report
on Bacterial Vaginosis

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 93 Outcomes
Top 200 Key Drugs and Biologics
Top 38 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>